What is it about?
Asians may gain greater protection from heart disease and strokes by taking drugs called GLP-1 receptor agonists for their diabetes compared to white persons with type 2 diabetes.
Featured Image
Read the Original
This page is a summary of: Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight o..., Diabetes Care, February 2025, American Diabetes Association,
DOI: 10.2337/dc24-1533.
You can read the full text:
Contributors
The following have contributed to this page
